Centre caps vaccine doses at Rs 250 at pvt hospitals; free of charge at govt centres

As India readies for phase-2 of COVID-19 vaccination, Union Health Secretary Rajesh Bhushan on Saturday, anunced that pricing for a vaccine dose has been capped at Rs 250 at private hospitals. While vaccine doses will be available free of cost at government centres, Centre will bear cost of iculation. As of date, 77% of health care workers have been administered with first dose and 70% got second dose - totalling 1,35,60,983 doses.

Phase 2 of COVID vaccination to start from March 1; iculation at private hospitals too

Vaccine doses capped at Rs 250/dose at pvt hospitals   

"Private hospitals functioning as COVID-19 Vaccination Centres may recover a charge subject to a ceiling of Rs 250 per person per dose. To ramp up COVID vaccination capacity a large number of private facilities are being involved- around 10,000 private hospitals empanelled under Ayushman Bharat PMJAY, more than 600 hospitals empanelled under CGHS & or private hospitals empanelled under State Govts," said Bhushan. Phase-2 of vaccination for people above 60 years of and those d above 45 years having comorbidities will begin on March 1.

Aadar Poonawalla meets Amit Shah, discusses COVID vaccine rollout ahead of Phase-2 drive

India's vaccine drive

On January 3, Drug Controller General of India (DCGI) VG Somani anunced that vaccines of Serum Institue of India (Covishield) and Bharat Biotech (Covaxin) have been granted permission for restricted use in an emergency situation. Covishield - a Recombinant Chimpanzee Adevirus vector vaccine - has an efficacy of 70.42%, with interim safety and immugenicity data of Phase-II/III trials submitted to SEC. Covaxin - a Whole Virion Inactivated Corona Virus Vaccine - 22,500 participants vaccinated in Phase-III trials and was found to be safe as per data available till date. Meanwhile, Zydus-Cadilla's nCov-Vaccine using DNA platform techlogy has been allowed to conduct Phase-III clinical trial in 26000 Indian participants. Apart from se vaccines, ar vaccine candidate - Sputnik V - produced by Russian government-Dr. Reddy's Labs has applied for emergency use and Bharat Biotech has sought to conduct phase-1 trials of nasal COVID-19 vaccine.

With Recovery Rate improving to 97.14%, India has become second-fastest fastest to administer 10 million COVID-vaccines doses - in 34 days. In comparison, US - fastest - took 31 days, stated Ministry of Health and Family welfare. UK and US, both kick-started ir iculation drives in December.

Centre sets March 6 deadline to complete 1st round COVID vaccination of frontline workers

India's administers 87,40,595 COVID-19 vaccine doses; active cases fall below 1.4 lakhs